These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 27692845)

  • 1. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire.
    Gelhorn HL; Dashiell-Aje E; Miller MG; DeRogatis LR; Dobs A; Seftel AD; Althof SE; Brod M; Revicki DA
    J Sex Med; 2016 Nov; 13(11):1737-1749. PubMed ID: 27692845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF).
    Gelhorn HL; Roberts LJ; Khandelwal N; Revicki DA; DeRogatis LR; Dobs A; Hepp Z; Miller MG
    J Sex Med; 2017 Aug; 14(8):1046-1058. PubMed ID: 28760247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the Hypogonadism Impact of Symptoms Questionnaire Short Form: Qualitative Research.
    Gelhorn HL; Bodhani AR; Wahala LS; Sexton C; Landrian A; Miller MG; Derogatis L; Dobs A; Revicki DA
    J Sex Med; 2016 Nov; 13(11):1729-1736. PubMed ID: 27717790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q): A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism.
    Gelhorn HL; Vernon MK; Stewart KD; Miller MG; Brod M; Althof SE; DeRogatis LR; Dobs A; Seftel AD; Revicki DA
    Patient; 2016 Apr; 9(2):181-90. PubMed ID: 26334870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction.
    Abraham L; Symonds T; Morris MF
    J Sex Med; 2008 Mar; 5(3):595-601. PubMed ID: 18208501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2.
    Wu F; Zitzmann M; Heiselman D; Donatucci C; Knorr J; Patel AB; Kinchen K
    J Sex Med; 2016 Aug; 13(8):1212-9. PubMed ID: 27329542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. German version of the Hypogonadism Impact of Symptoms Questionnaire: Psychometric properties and association with testosterone levels.
    Schmidt MK; Rohayem J; Zitzmann M; Gelhorn H; Schneider G
    Andrologia; 2022 May; 54(4):e14370. PubMed ID: 35060154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric testing of two new patient-reported outcome instruments for the evaluation of treatment for hypogonadism.
    Hayes RP; Ni X; Heiselman DE; Kinchen K
    Int J Clin Pract; 2016 Jul; 70(7):587-95. PubMed ID: 27291501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea.
    Shigehara K; Konaka H; Sugimoto K; Nohara T; Izumi K; Kadono Y; Namiki M; Mizokami A
    Aging Male; 2018 Jun; 21(2):99-105. PubMed ID: 28920756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ostomy-Q: Development and Psychometric Validation of an Instrument to Evaluate Outcomes Associated with Ostomy Appliances.
    Nafees B; Rasmussen M; LLoyd A
    Ostomy Wound Manage; 2017 Jan; 63(1):12-22. PubMed ID: 28112646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A menopause-specific quality of life questionnaire: development and psychometric properties.
    Hilditch JR; Lewis J; Peter A; van Maris B; Ross A; Franssen E; Guyatt GH; Norton PG; Dunn E
    Maturitas; 1996 Jul; 24(3):161-75. PubMed ID: 8844630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further psychometric validation of the sexual life quality questionnaire for men with erectile dysfunction and their partners on a modified Spanish language version.
    Gutiérrez P; Hernández P; Sanz E; Cardeñosa O; Mas M
    J Sex Med; 2009 Oct; 6(10):2698-706. PubMed ID: 19453884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
    Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
    J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity and Clinically Meaningful Changes in the Psychosexual Daily Questionnaire and Derogatis Interview for Sexual Function Assessment: Results From the Testosterone Trials.
    Wang C; Stephens-Shields AJ; DeRogatis LR; Cunningham GR; Swerdloff RS; Preston P; Cella D; Snyder PJ; Gill TM; Bhasin S; Matsumoto AM; Rosen RC
    J Sex Med; 2018 Jul; 15(7):997-1009. PubMed ID: 29960633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the sexual experience in men: validation of the sexual experience questionnaire.
    Mulhall JP; King R; Kirby M; Hvidsten K; Symonds T; Bushmakin AG; Cappelleri JC
    J Sex Med; 2008 Feb; 5(2):365-76. PubMed ID: 18179460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study.
    Huxley P; Evans S; Madge S; Webber M; Burchardt T; McDaid D; Knapp M
    Health Technol Assess; 2012; 16(1):iii-vii, ix-xii, -1-241. PubMed ID: 22260923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosscultural Adaptation and Validation of the Korean Version of the New Knee Society Knee Scoring System.
    Kim SJ; Basur MS; Park CK; Chong S; Kang YG; Kim MJ; Jeong JS; Kim TK
    Clin Orthop Relat Res; 2017 Jun; 475(6):1629-1639. PubMed ID: 28265885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.